Clearance of extracellular misfolded proteins in systemic amyloidosis: Experience with transthyretin

被引:23
作者
Almeida, Maria Rosario [1 ]
Saraiva, Maria Joao [1 ]
机构
[1] Univ Porto, IBMC, P-4150 Oporto, Portugal
关键词
Transthyretin; Amyloid; Clusterin; Doxycycline; EGCG (epigallocatechin gallate); TRANSGENIC MOUSE MODEL; HEAT-SHOCK RESPONSE; CLUSTERIN; DEPOSITION; TTR; POLYNEUROPATHY; CHAPERONE; FIBRILS; NEURODEGENERATION; POLYPHENOLS;
D O I
10.1016/j.febslet.2012.07.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increasing evidence indicates that accumulation of misfolded proteins in the form of oligomers, protofibrils or amyloid fibrils, and their consequences in triggering intracellular signaling cascades with toxic consequences represent unifying events in many of slowly progressive neurodegenerative disorders. Studies with small compounds or molecules, known to recognize and disrupt amyloidogenic structures, have proven efficient in promoting clearance of protein aggregates in experimental models of systemic and localized forms of amyloidoses. Doxycycline and EGCG were efficient in removing aggregates in pre-clinical studies in a transgenic mouse model for transthyretin (TTR) systemic amyloidosis and represent an opportunity to address mechanisms and key players in deposit removal. Extracellular chaperones, such as clusterin and metalloproteinases play an important role in this process. (C) 2012 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:2891 / 2896
页数:6
相关论文
共 44 条
[1]  
Almeida M. R., 2005, Current Drug Targets - CNS and Neurological Disorders, V4, P587, DOI 10.2174/156800705774322076
[2]  
Alvarez R, 2010, AMYLOID, V17, P51
[3]   EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity [J].
Bieschke, Jan ;
Russ, Jenny ;
Friedrich, Ralf P. ;
Ehrnhoefer, Dagmar E. ;
Wobst, Heike ;
Neugebauer, Katja ;
Wanker, Erich E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) :7710-7715
[4]   Antibodies to human serum amyloid P component eliminate visceral amyloid deposits [J].
Bodin, Karl ;
Ellmerich, Stephan ;
Kahan, Melvyn C. ;
Tennent, Glenys A. ;
Loesch, Andrzej ;
Gilbertson, Janet A. ;
Hutchinson, Winston L. ;
Mangione, Palma P. ;
Gallimore, J. Ruth ;
Millar, David J. ;
Minogue, Shane ;
Dhillon, Amar P. ;
Taylor, Graham W. ;
Bradwell, Arthur R. ;
Petrie, Aviva ;
Gillmore, Julian D. ;
Bellotti, Vittorio ;
Botto, Marina ;
Hawkins, Philip N. ;
Pepys, Mark B. .
NATURE, 2010, 468 (7320) :93-97
[5]   Extracellular matrix markers for disease progression and follow-up of therapies in Familial Amyloid Polyneuropathy V30M TTR-related [J].
Cardoso, I. ;
Brito, M. ;
Saraiva, M. J. .
DISEASE MARKERS, 2008, 25 (01) :37-47
[6]   Doxycycline disrupts transthyretin amyloid: evidence from studies in a FAP transgenic mice model [J].
Cardoso, I. ;
Saraiva, M. J. .
FASEB JOURNAL, 2006, 20 (02) :234-239
[7]   4′-iodo-4′-Deoxydoxorubicin and tetracyclines disrupt transthyretin amyloid fibrils in vitro producing noncytotoxic species:: screening for TTR fibril disrupters [J].
Cardoso, I ;
Merlini, G ;
Saraiva, MJ .
FASEB JOURNAL, 2003, 17 (08) :803-809
[8]   Synergy of combined Doxycycline/TUDCA treatment in lowering Transthyretin deposition and associated biomarkers: studies in FAP mouse models [J].
Cardoso, Isabel ;
Martins, Diana ;
Ribeiro, Tania ;
Merlini, Giampaolo ;
Saraiva, Maria Joao .
JOURNAL OF TRANSLATIONAL MEDICINE, 2010, 8
[9]  
Coelho T., 2011, NEUROLOGY IN PRESS
[10]   EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers [J].
Ehrnhoefer, Dagmar E. ;
Bieschke, Jan ;
Boeddrich, Annett ;
Herbst, Martin ;
Masino, Laura ;
Lurz, Rudi ;
Engemann, Sabine ;
Pastore, Annalisa ;
Wanker, Erich E. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (06) :558-566